36 completed, 3 recruiting, 2 terminated, 2 unknown. 45 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 45 | Completed 36, Recruiting 3, Terminated 2, Unknown 2, Withdrawn 2 |
Follow Testosterone: new trials by email Literature Review of Testosterone trials Research Report on Testosterone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance Biopsy of Prostate, Biospecimen Collection, Magnetic Resonance Imaging - Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 | Phase 4 | Recruiting | Roswell Park Cancer Institute | 600 | 2025-01-15 | 2026-05-14 |
| Klinefelter Syndrome and Testosterone Treatment in Puberty Testosterone gel, Placebo - Klinefelter Syndrome | Phase 4 | Recruiting | Lise Aksglæde | 32 | 2024-08-15 | 2025-02-19 |
| Adaptions and Resiliency to Multi-Stressor OpeRations Goserelin 3.6 MG, Multi-Stressor Training, Testosterone gel (AndroGel 5g) - Musculoskeletal Injury, Hypogonadism | Phase 4 | Recruiting | Bradley Nindl | 120 | 2024-07-15 | 2026-08-18 |
| Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening Progesterone, Ibutilide, Testosterone - Long QT Syndrome, Abnormalities, Drug-Induced | Phase 4 | Completed | Indiana University | 73 | 2021-09-02 | 2026-10-20 |
| A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism Aveed Injectable Product, Fortesta, Testim - Hypogonadism, Hypogonadism, Male | Phase 4 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 673 | 2020-06-30 | 2025-03-14 |
| A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants Androderm® - Hypogonadism | Phase 4 | Completed | Allergan | 168 | 2020-05-19 | 2022-07-12 |
| Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism Testosterone gel 1.62%, Placebo - Type 2 Diabetes Mellitus, Hypogonadism | Phase 4 | Completed | VA Office of Research and Development | 92 | 2019-10-01 | 2026-04-29 |
| A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men AndroGel®, Placebo - Hypogonadism, Cardiovascular Diseases | Phase 4 | Completed | AbbVie | 5246 | 2018-05-03 | 2024-03-13 |
| A Multinomial Process Model of Moral Judgment Testosterone, Placebo - Testosterone, Placebos | Phase 4 | Completed | Robert Josephs | 206 | 2017-08-30 | 2026-09-28 |
| Subcutaneous vs. Intramuscular Testosterone Testosterone - Testosterone Deficiency, Hypogonadism, Male | Phase 4 | Completed | Men's Health Boston | 4 | 2017-08-29 | 2019-10-08 |
| Effects of Sex Steroids on the Serotonin System Testosterone, Lynestrenol, Cyproterone Acetate - Gender Dysphoria | Phase 4 | Unknown | Medical University of Vienna | 92 | 2017-02-06 | 2018-10-15 |
| Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes Testosterone, Progesterone, Placebo - Long QT Syndrome | Phase 4 | Completed | Indiana University | 14 | 2016-05-01 | 2019-08-28 |
| Intranasal Delivery of Testosterone and Its Effect on Doping Markers Testosterone - Abuse of Anabolic Steroids | Phase 4 | Completed | University of Utah | 5 | 2015-11-18 | 2020-02-11 |
| Testosterone Therapy in Hypogonadal Men Treated With Opioids Testosterone, placebo - Hypogonadism | Phase 4 | Completed | Marianne Andersen | 40 | 2015-05-01 | 2020-09-16 |
| Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism. liraglutide, Testosterone - Hypogonadism, Obesity | Phase 4 | Completed | University Medical Centre Ljubljana | 30 | 2014-12-01 | 2018-08-07 |
| Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism Testosterone - Type 2 Diabetes, Hypogonadism | Phase 4 | Terminated | Tameside Hospital NHS Foundation Trust | 22 | 2013-10-11 | 2019-04-04 |
| Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment Testosterone - Hypogonadism | Phase 4 | Completed | Gulhane School of Medicine | 150 | 2013-07-01 | 2014-04-14 |
| Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) Testosterone, Placebo - Type 2 Diabetes Mellitus, Hypogonadism | Phase 4 | Completed | Marianne Andersen | 43 | 2012-03-01 | 2013-11-14 |
| Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Androgel (Testosterone Gel), Placebo gel - Endocrine Dysfunction, Trauma | Phase 4 | Completed | Craig Hospital | 46 | 2010-09-01 | 2021-07-27 |
| Testosterone Replacement in Men With Diabetes and Obesity testosterone, placebo - Hypogonadism | Phase 4 | Completed | University at Buffalo | 137 | 2010-05-01 | 2022-11-29 |
Showing 20 of 45. Sign in to see all of them.
Hypogonadism (30) · Diabetes Mellitus (7) · Diabetes Mellitus, Type 2 (5) · Insulin Resistance (5) · Obesity (5) · Metabolic Syndrome (4) · Inflammation (3) · Erectile Dysfunction (2) · Eunuchism (2) · Frailty (2) · Long QT Syndrome (2) · Peripheral Vascular Diseases (2) · Sarcopenia (2) · Abnormalities, Drug-Induced (1) · Atherosclerosis (1)
Gulhane School of Medicine (8) · Barnsley Hospital (3) · Indiana University (2) · Marianne Andersen (2) · University at Buffalo (2) · AbbVie (1) · Allergan (1) · Boston Medical Center (1) · Boston University (1) · Bradley Nindl (1) · Brigham and Women's Hospital (1) · Craig Hospital (1) · Diabetes Center of the Southwest (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Lise Aksglæde (1)
United States (26) · Turkey (Türkiye) (8) · Denmark (4) · United Kingdom (4) · Puerto Rico (2) · Austria (1) · Israel (1) · Italy (1) · Slovenia (1)
Shalender Bhasin, MD (3) · James E Tisdale, PharmD (2) · Abraham Morgentaler, MD (1) · Ahmed Aly (1) · Alvin M Matsumoto, MD (1) · Andrea Lenzi, MD, PhD (1) · Andrea M Isidori, MD, PhD (1) · Andrej Janez, MD, PhD (1) · Anna Chan (1) · Anne Kenny, MD (1) · Aydogan Aydogdu, MD (1) · Bradley C Nindl, PhD (1) · Cecilia Shikuma (1) · David Hernandez (1)
PMID 28981994, PMID 38224135, PMID 16260965, PMID 18996225, PMID 20520285, PMID 20592293, PMID 20722847, PMID 21575967, PMID 21697501, PMID 23165659, PMID 23292288, PMID 23494931, PMID 23730808, PMID 24089589, PMID 24106072, PMID 26262795, PMID 26622051, PMID 27377542, PMID 27754805, PMID 27992261, PMID 28168203, PMID 28950424, PMID 29373734, PMID 29656500, PMID 29846604, PMID 30629183, PMID 31858126, PMID 32250330, PMID 32853647, PMID 33020898, PMID 33718653, PMID 35665818, PMID 35790332, PMID 36171900, PMID 37326322, PMID 37889486, PMID 38088425, PMID 38150256, PMID 38216784, PMID 38231621, PMID 38315466, PMID 39668628, PMID 40090688, PMID 40246046
2023 (1), I01CX001665 (1), R01AG018887 (1), R01DK075877 (1), R01HD047722 (1), R01HL153114 (1), U01AG014369 (1)